{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:42:49Z","timestamp":1781728969755,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,27]],"date-time":"2013-10-27T00:00:00Z","timestamp":1382832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00277-013-1937-4","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T19:42:18Z","timestamp":1382816538000},"page":"71-80","source":"Crossref","is-referenced-by-count":73,"title":["Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV"],"prefix":"10.1007","volume":"93","author":[{"name":"German Chronic Myeloid Leukemia Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Kalmanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Schweizerische Arbeitsgemeinschaft f\u00fcr Klinische Krebsforschung (SAKK)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Saussele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lauseker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Proetel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hanfstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Fabarius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Pfirrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schnittger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Dengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Falge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Stegelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius F.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Spiekermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan W.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Nerl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter K.","family":"Hossfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Jochem","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Hasford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Hehlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,27]]},"reference":[{"key":"1937_CR1","unstructured":"Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Altekruse S, Kosary C, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner M, Lewis D, Chen H, Feuer E, Cronin K, (Editors) SEER Cancer Statistics Review, 1975\u20132009 (Vintage 2009 Populations).Bethesda, MD:National Cancer Institute;2012http:\/\/seer.cancer.gov\/csr\/1975_2009_pops09\/. Accessed 10 March 2012"},{"issue":"18","key":"1937_CR2","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1200\/JCO.2011.34.7146","volume":"29","author":"M Bjorkholm","year":"2011","unstructured":"Bjorkholm M, Ohm L, Eloranta S, Derolf A, Hultcrantz M, Sjoberg J, Andersson T, Hoglund M, Richter J, Landgren O, Kristinsson SY, Dickman PW (2011) Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol 29(18):2514\u20132520. doi: 10.1200\/jco.2011.34.7146","journal-title":"J Clin Oncol"},{"issue":"3","key":"1937_CR3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/leu.2008.245","volume":"23","author":"M Rohrbacher","year":"2009","unstructured":"Rohrbacher M, Berger U, Hochhaus A, Metzgeroth G, Adam K, Lahaye T, Saussele S, M\u00fcller MC, Hasford J, Heimpel H, Hehlmann R (2009) Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph\/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany. Leuk 23(3):602\u2013604. doi: 10.1038\/leu.2008.245","journal-title":"Leuk"},{"issue":"4","key":"1937_CR4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","volume":"63","author":"JE Sokal","year":"1984","unstructured":"Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE, Tso CY, Braun TJ, Clarkson BD, Cervantes F, Rozman C (1984) Prognostic discrimination in \"good-risk\" chronic granulocytic leukemia. Blood 63(4):789\u2013799","journal-title":"Blood"},{"issue":"11","key":"1937_CR5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","volume":"90","author":"J Hasford","year":"1998","unstructured":"Hasford J, Pfirrmann M, Hehlmann R, Allan NC, Baccarani M, Kluin-Nelemans JC, Alimena G, Steegmann JL, Ansari H (1998) A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst 90(11):850\u2013858","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1937_CR6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/cncr.11629","volume":"98","author":"J Cortes","year":"2003","unstructured":"Cortes J, Talpaz M, O\u2019Brien S, Giles F, Rios MB, Shan JQ, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Kantarjian H (2003) Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer 98(6):1105\u20131113. doi: 10.1002\/cncr.11629","journal-title":"Cancer"},{"issue":"1","key":"1937_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3324\/haematol.10239","volume":"92","author":"G Rosti","year":"2007","unstructured":"Rosti G, Iacobucci I, Bassi S, Castagnetti F, Amabile M, Cilloni D, Poerio A, Soverini S, Palandri F, Cambrin GR, Iuliano F, Alimena G, Latagliata R, Testoni N, Pane F, Saglio G, Baccarani M, Martinelli G (2007) Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party. Haematol 92(1):101\u2013105. doi: 10.3324\/haematol.10239","journal-title":"Haematol"},{"issue":"21","key":"1937_CR8","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1182\/blood-2010-12-324228","volume":"117","author":"G Gugliotta","year":"2011","unstructured":"Gugliotta G, Castagnetti F, Palandri F, Breccia M, Intermesoli T, Capucci A, Martino B, Pregno P, Rupoli S, Ferrero D, Gherlinzoni F, Montefusco E, Bocchia M, Tiribelli M, Pierri I, Grifoni F, Marzocchi G, Amabile M, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M, Rosti G (2011) Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party. Blood 117(21):5591\u20135599. doi: 10.1182\/blood-2010-12-324228","journal-title":"Blood"},{"issue":"7","key":"1937_CR9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3324\/haematol.2011.056721","volume":"97","author":"N Pemmaraju","year":"2012","unstructured":"Pemmaraju N, Kantarjian H, Shan J, Jabbour E, Quintas-Cardama A, Verstovsek S, Ravandi F, Wierda W, O'Brien S, Cortes J (2012) Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy. Haematol Hematol J 97(7):1029\u20131035. doi: 10.3324\/haematol.2011.056721","journal-title":"Haematol Hematol J"},{"issue":"1","key":"1937_CR10","first-page":"21","volume":"2010","author":"W Stock","year":"2010","unstructured":"Stock W (2010) Adolescents and young adults with acute lymphoblastic leukemia. ASH Educ Program Book 2010(1):21\u201329. doi: 10.1182\/asheducation-2010.1.21","journal-title":"ASH Educ Program Book"},{"key":"1937_CR11","first-page":"285","volume":"2013","author":"AS Advani","year":"2013","unstructured":"Advani AS (2013) Biology and treatment of acute lymphocytic leukemia in adolescents and young adults. ASCO Educ Book 2013:285\u2013289","journal-title":"ASCO Educ Book"},{"issue":"3","key":"1937_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.seminoncol.2009.03.001","volume":"36","author":"CK Anders","year":"2009","unstructured":"Anders CK, Johnson R, Litton J, Phillips M, Bleyer A (2009) Breast cancer before age 40\u00a0years. Semin Oncol 36(3):237\u2013249. doi: 10.1053\/j.seminoncol.2009.03.001","journal-title":"Semin Oncol"},{"issue":"20","key":"1937_CR13","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26(20):3324\u20133330. doi: 10.1200\/jco.2007.14.2471","journal-title":"J Clin Oncol"},{"issue":"2","key":"1937_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM200001133420216","volume":"342","author":"RV Datta","year":"2000","unstructured":"Datta RV, LaQuaglia MP, Paty PB (2000) Genetic and phenotypic correlates of colorectal cancer in young patients. New Eng J Med 342(2):137\u2013138. doi: 10.1056\/NEJM200001133420216","journal-title":"New Eng J Med"},{"issue":"4","key":"1937_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.mph.0000157790.81329.47","volume":"27","author":"S Prakash","year":"2005","unstructured":"Prakash S, Sarran L, Socci N, DeMatteo RP, Eisenstat J, Greco AM, Maki RG, Wexler LH, LaQuaglia MP, Besmer P, Antonescu CR (2005) Gastrointestinal stromal tumors in children and young adults\u2014a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol 27(4):179\u2013187. doi: 10.1097\/01.mph.0000157790.81329.47","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"1937_CR16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrc2349","volume":"8","author":"A Bleyer","year":"2008","unstructured":"Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B (2008) The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8(4):288\u2013298. doi: 10.1038\/nrc2349","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1937_CR17","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1200\/JCO.2010.32.0598","volume":"29","author":"R Hehlmann","year":"2011","unstructured":"Hehlmann R, Lauseker M, Jung-Munkwitz S, Leitner A, Mueller MC, Pletsch N, Proetel U, Haferlach C, Schlegelberger B, Balleisen L, Haenel M, Pfirrmann M, Krause SW, Nerl C, Pralle H, Gratwohl A, Hossfeld DK, Hasford J, Hochhaus A, Saussele S (2011) Tolerability-adapted imatinib 800\u00a0mg\/d versus 400 mg\/d versus 400 mg\/d plus interferon-alpha in newly diagnosed chronic myeloid leukemia. J Clin Oncol 29(12):1634\u20131642. doi: 10.1200\/jco.2010.32.0598","journal-title":"J Clin Oncol"},{"issue":"1","key":"1937_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mpo.1257","volume":"38","author":"WA Bleyer","year":"2002","unstructured":"Bleyer WA (2002) Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 38(1):1\u201310. doi: 10.1002\/mpo.1257","journal-title":"Med Pediatr Oncol"},{"issue":"32","key":"1937_CR19","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1200\/JCO.2009.22.4543","volume":"28","author":"S Wein","year":"2010","unstructured":"Wein S, Pery S, Zer A (2010) Role of palliative care in adolescent and young adult oncology. J Clin Oncol 28(32):4819\u20134824. doi: 10.1200\/jco.2009.22.4543","journal-title":"J Clin Oncol"},{"issue":"32","key":"1937_CR20","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1200\/JCO.2009.23.8097","volume":"28","author":"A Ferrari","year":"2010","unstructured":"Ferrari A, Thomas D, Franklin ARK, Hayes-Lattin BM, Mascarin M, van der Graaf W, Albritton KH (2010) Starting an adolescent and young adult program: some success stories and some obstacles to overcome. J Clin Oncol 28(32):4850\u20134857. doi: 10.1200\/jco.2009.23.8097","journal-title":"J Clin Oncol"},{"issue":"10","key":"1937_CR21","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/cncr.26058","volume":"117","author":"ES Tonorezos","year":"2011","unstructured":"Tonorezos ES, Oeffinger KC (2011) Research challenges in adolescent and young adult cancer survivor research. Cancer 117(10):2295\u20132300. doi: 10.1002\/cncr.26058","journal-title":"Cancer"},{"issue":"3","key":"1937_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.leukres.2004.08.002","volume":"29","author":"R Latagliata","year":"2005","unstructured":"Latagliata R, Breccia M, Carmosino I et al (2005) Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment. Leukemia Research 29(3):287\u2013291. doi: doi:dx.doi.org\/10.1016\/j.leukres.2004.08.002","journal-title":"Leukemia Research"},{"issue":"26","key":"1937_CR23","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","volume":"118","author":"A Fabarius","year":"2011","unstructured":"Fabarius A, Leitner A, Hochhaus A, M\u00fcller MC, Hanfstein B, Haferlach C, Gohring G, Schlegelberger B, Jotterand M, Reiter A, Jung-Munkwitz S, Proetel U, Schwaab J, Hofmann WK, Schubert J, Einsele H, Ho AD, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Baerlocher GM, Lauseker M, Pfirrmann M, Hasford J, Saussele S, Hehlmann R (2011) Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood 118(26):6760\u20136768. doi: 10.1182\/blood-2011-08-373902","journal-title":"Blood"},{"issue":"1","key":"1937_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","volume":"108","author":"T Hughes","year":"2006","unstructured":"Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J, Baccarani M, Cortes J, Cross NC, Druker BJ, Gabert J, Grimwade D, Hehlmann R, Kamel-Reid S, Lipton JH, Longtine J, Martinelli G, Saglio G, Soverini S, Stock W, Goldman JM (2006) Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 108(1):28\u201337. doi: 2006-01-0092 [pii]10.1182\/blood-2006-01-0092","journal-title":"Blood"},{"issue":"11","key":"1937_CR25","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/sj.leu.2401566","volume":"13","author":"M Emig","year":"1999","unstructured":"Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross NCP, Hochhaus A (1999) Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leuk 13(11):1825\u20131832. doi: 10.1038\/sj.leu.2401566","journal-title":"Leuk"},{"issue":"3","key":"1937_CR26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beha.2009.04.001","volume":"22","author":"NC Cross","year":"2009","unstructured":"Cross NC (2009) Standardisation of molecular monitoring for chronic myeloid leukaemia. Best Pract Res Clin Haematol 22(3):355\u2013365","journal-title":"Best Pract Res Clin Haematol"},{"issue":"11","key":"1937_CR27","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/leu.2009.168","volume":"23","author":"MC Muller","year":"2009","unstructured":"Muller MC, Cross NCP, Erben P, Schenk T, Hanfstein B, Ernst T, Hehlmann R, Branford S, Saglio G, Hochhaus A (2009) Harmonization of molecular monitoring of CML therapy in Europe. Leuk 23(11):1957\u20131963. doi: 10.1038\/leu.2009.168","journal-title":"Leuk"},{"issue":"35","key":"1937_CR28","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","volume":"27","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27(35):6041\u20136051. doi: 10.1200JCO.2009.25.0779","journal-title":"J Clin Oncol"},{"issue":"10","key":"1937_CR29","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/leu.2012.104","volume":"26","author":"NCP Cross","year":"2012","unstructured":"Cross NCP, White HE, M\u00fcller MC, Saglio G, Hochhaus A (2012) Standardized definitions of molecular response in chronic myeloid leukemia. Leuk 26(10):2172\u20132175","journal-title":"Leuk"},{"issue":"6","key":"1937_CR30","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","volume":"108","author":"M Baccarani","year":"2006","unstructured":"Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R (2006) Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 108(6):1809\u20131820. doi: 10.1182\/blood-2006-02-005686","journal-title":"Blood"},{"issue":"9","key":"1937_CR31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/leu.2011.116","volume":"25","author":"M Pfirrmann","year":"2011","unstructured":"Pfirrmann M, Hochhaus A, Lauseker M, Sausele S, Hehlmann R, Hasford J (2011) Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia. Leukemia 25(9):1433\u20131438","journal-title":"Leukemia"},{"issue":"6","key":"1937_CR32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"T Gooley","year":"1999","unstructured":"Gooley T, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competiting risks:new representations of old estimators. Stat Med 18(6):695\u2013706","journal-title":"Stat Med"},{"issue":"3","key":"1937_CR33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ (1988) A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16(3):1141\u20131154. doi: 10.1214\/aos\/1176350951","journal-title":"Ann Stat"},{"key":"1937_CR34","unstructured":"Statistical Yearbook for the Federal Republic of Germany including \"International tables\" (2011). Federal Statistical Office, Wiesbaden"},{"key":"1937_CR35","unstructured":"Bleyer A OLM, Barr R, Ries LAG (eds): Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival:1975\u20132000. National Cancer Institute, NIH Pub. No. 06\u20135767. Bethesda, MD 2006. http:\/\/seer.cancer.gov\/publications\/aya\/ . Accessed 10 March 2012."},{"issue":"2","key":"1937_CR36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0609.2008.01170.x","volume":"82","author":"R Adler","year":"2009","unstructured":"Adler R, Viehmann S, Kuhlisch E, Martiniak Y, R\u00f6ttgers S, Harbott J, Suttorp M (2009) Correlation of BCR\/ABL transcript variants with patients characteristics in childhood chronic myeloid leukemia. Eur J Haematol 82(2):112\u2013118","journal-title":"Eur J Haematol"},{"issue":"21","key":"1937_CR37","first-page":"3741","volume":"120","author":"F Millot","year":"2012","unstructured":"Millot F, Suttorp M, Guilhot J, Sedlacek P, De Bont ES, Li CK, Kalwak K, Lausen B, Srdjana C, Dresse M-F, Biondi A, Baruchel A (2012) The International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped-Study): objectives and preliminary results. ASH Annu Meeting Abstracts 120(21):3741","journal-title":"ASH Annu Meeting Abstracts"},{"issue":"1","key":"1937_CR38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1542\/peds.2004-2473","volume":"116","author":"F Millot","year":"2005","unstructured":"Millot F, Traore P, Guilhot J, Nelken B, Leblanc T, Leverger G, Plantaz D, Bertrand Y, Bordigoni P, Guilhot F (2005) Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatr 116(1):140\u2013143. doi: 10.1542\/peds.2004-2473","journal-title":"Pediatr"},{"issue":"9","key":"1937_CR39","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/leu.2012.85","volume":"26","author":"B Hanfstein","year":"2012","unstructured":"Hanfstein B, M\u00fcller MC, Hehlmann R, Erben P, Lauseker M, Fabarius A, Schnittger S, Haferlach C, Goehring G, Proetel U, Kolb HJ, Krause SW, Hofmann WK, Schubert J, Einsele H, Dengler J, Haenel M, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Branford S, Hughes TP, Spiekermann K, Baerlocher GM, Pfirrmann M, Hasford J, Saussele S, Hochhaus A, Sakk GCMLSG (2012) Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leuk 26(9):2096\u20132102. doi: 10.1038\/leu.2012.85","journal-title":"Leuk"},{"issue":"3","key":"1937_CR40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1200\/JCO.2011.38.6565","volume":"30","author":"D Marin","year":"2012","unstructured":"Marin D, Ibrahim AR, Lucas C, Gerrard G, Wang L, Szydlo RM, Clark RE, Apperley JF, Milojkovic D, Bua M, Pavlu J, Paliompeis C, Reid A, Rezvani K, Goldman JM, Foroni L (2012) Assessment of BCR-ABL1 transcript levels at 3\u00a0months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. J Clin Oncol 30(3):232\u2013238. doi: 10.1200\/jco.2011.38.6565","journal-title":"J Clin Oncol"},{"key":"1937_CR41","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Martinelli G, Mayer J, Muller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saussele S, Schiffer C, Silver R, Simonsson B, Steegmann JL, Goldman JM, Hehlmann R (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. doi: 10.1182\/blood-2013-05-501569","journal-title":"Blood"},{"issue":"2","key":"1937_CR42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","volume":"342","author":"R Gryfe","year":"2000","unstructured":"Gryfe R, Kim H, Hsieh ETK, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342(2):69\u201377. doi: 10.1056\/nejm200001133420201","journal-title":"N Engl J Med"},{"issue":"2","key":"1937_CR43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cncr.25369","volume":"117","author":"M Vriens","year":"2011","unstructured":"Vriens M, Moses W, Weng J et al (2011) Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer 117(2):259\u2013267","journal-title":"Cancer"},{"issue":"2","key":"1937_CR44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07417.x","volume":"144","author":"CJ Harrison","year":"2009","unstructured":"Harrison CJ (2009) Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 144(2):147\u2013156. doi: 10.1111\/j.1365-2141.2008.07417.x","journal-title":"Br J Haematol"},{"issue":"6","key":"1937_CR45","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4161\/cbt.6.6.4101","volume":"6","author":"F Belloc","year":"2007","unstructured":"Belloc F, Moreau-Gaudry F, Uhalde M, Cazalis L, Jeanneteau M, Lacombe F, Praloran V, Mahon F-X (2007) Imatinib and Nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines. Cancer Biology & Therapy 6(6):912\u2013919","journal-title":"Cancer Biology & Therapy"},{"issue":"10","key":"1937_CR46","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","volume":"121","author":"B Zhang","year":"2013","unstructured":"Zhang B, Li M, McDonald T, Holyoake TL, Moon RT, Campana D, Shultz L, Bhatia R (2013) Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt\u2013\u03b2-catenin signaling. Blood 121(10):1824\u20131838. doi: 10.1182\/blood-2012-02-412890","journal-title":"Blood"},{"issue":"7","key":"1937_CR47","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/leu.2013.19","volume":"27","author":"S Mustjoki","year":"2013","unstructured":"Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevarn B, Olofsson T, Olsson-Stromberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H (2013) Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients. Leuk 27(7):1520\u20131526. doi: 10.1038\/leu.2013.19","journal-title":"Leuk"},{"issue":"23","key":"1937_CR48","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355(23):2408\u20132417. doi: 10.1056\/NEJMoa062867","journal-title":"N Engl J Med"},{"issue":"7","key":"1937_CR49","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3109\/0284186X.2012.705891","volume":"51","author":"KKVGC Aben","year":"2012","unstructured":"Aben KKVGC, Van Gils NA, Van der Graaf WT, Zielhuis GA (2012) Cancer in adolescents and young adults (15\u201329 years): a population-based study in the Netherlands 1989\u20132009. Acta Oncologica 51(7):922\u2013933. doi: 10.3109\/0284186X.2012.705891","journal-title":"Acta Oncologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1937-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1937-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1937-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T21:02:42Z","timestamp":1596747762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1937-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,27]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1937-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,27]]}}}